Analystreport

Arcus Biosciences (NYSE:RCUS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report